Online Inquiry
Cat.#: ASSD-138
| Description | A3AR covalent antagonist.Binds irreversibly. Apparent pKi values at A3ARs are 6.9 and 8.0 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-(8-Methoxy-2,4-dioxo-3-propylpurino[7,8-a]pyridin-1-yl)propylcarbamoyl]benzenesulfonyl fluoride |
| Molecule Weight | 517.5 |
| Molecular formula | C23H24FN5O6S |
| PubChem identifier | 155513958 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
| ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
| ASSD-182 | 9-(2-Carboxy-2-cyanovinyl)julolidine (AC182) | 5 mg | inquiry |
| ASSD-181 | Nitrofluorescein, Isomer 1 (AC181) | 1 g | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-180 | Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 (AC180) | 1 mg | inquiry |
| ASSD-156 | Crystal Violet (AC156) | 1g, 5g | inquiry |
| ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.